Definium Therapeutics Inc. Common Shares (DFTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Definium Therapeutics Inc. Common Shares, updated every trading day.
Health Care · Medicinal Chemicals and Botanical Products
Price
$38.10
+2.75% today
Market cap
$5.0B
Overall quality
48/100
Kronos AI 30-day
+10.9%
6 of 8 simulated paths end higher
Definium Therapeutics Inc. Common Shares (DFTX) is a Health Care company in Medicinal Chemicals and Botanical Products, worth $5.0B. It trades at $38.10, up 2.75% today. Its overall quality score is 48 out of 100, ranked against the whole US market. 15 analysts' average target of $72.75 implies +90.9% from today's price. Kronos AI's 30-day forecast is +10.9% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $72.75 |
| Low – high | $53.00 – $91.00 |
| Analysts | 15 |
| Upside to average | +90.9% |
Kronos AI 30-day forecast
| Expected close | $41.14 (+10.9%) |
| Likely range | −16.6% … +17.9% |
| As of | 2026-10-27 |
6 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 74 |
| Growth | 30 |
| Overall | 48 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medicinal Chemicals and Botanical Products
- PM — Philip Morris International Inc
- BTI — British American Tobacco Industries p.l.c.
- MO — Altria Group Inc.
- RGC — Regencell Bioscience Holdings Limited
- TRLV — Trulieve Cannabis Corp. Subordinate Voting Shares
- RLX — RLX Technology Inc. American Depositary Shares each representing the right to receive one (1)
For information only, not investment advice. Prices updated: 2026-10-29.